IMI
The project involves numerous biopharmaceutical firms, including Pfizer, Roche, Takeda Pharmaceuticals, Sanofi, Novartis, ProQR Therapeutics, Lysogene, and Novo Nordisk.
The firm is also developing an instrument-free molecular diagnostic assay technology for the home testing market.
The effort, called FAIRplus, commenced earlier this year with a budget of €8.2 million, funded by the Innovative Medicine Initiative.
EU Approves $4.77B Innovative Medicines Initiative Plan
NEW YORK (GenomeWeb News) – The European Union Parliament has approved a €3.45 billion ($4.77 billion) plan that will use funding from the EU and private and public sector partners to fund biomedical research programs aimed at improving biomarkers, clinical trials, new drugs, and programs that he
Roche, IMI Lead Stem Cell Research Effort
NEW YORK (GenomeWeb News) – Roche today announced that it has teamed with the Innovative Medicines Initiative to lead a consortium of industry and academic partners that will use stem cells for drug discovery research.